ArticleArthritis research & therapy2025

Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study.

Teppei Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.